These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. FKBP12-immunopositive inclusions in patients with α-synucleinopathies. Honjo Y; Ayaki T; Horibe T; Ito H; Takahashi R; Kawakami K Brain Res; 2018 Feb; 1680():39-45. PubMed ID: 29246765 [TBL] [Abstract][Full Text] [Related]
8. Propagation of pathological α-synuclein in marmoset brain. Shimozawa A; Ono M; Takahara D; Tarutani A; Imura S; Masuda-Suzukake M; Higuchi M; Yanai K; Hisanaga SI; Hasegawa M Acta Neuropathol Commun; 2017 Feb; 5(1):12. PubMed ID: 28148299 [TBL] [Abstract][Full Text] [Related]
9. α-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Peelaerts W; Bousset L; Van der Perren A; Moskalyuk A; Pulizzi R; Giugliano M; Van den Haute C; Melki R; Baekelandt V Nature; 2015 Jun; 522(7556):340-4. PubMed ID: 26061766 [TBL] [Abstract][Full Text] [Related]
10. E46K human alpha-synuclein transgenic mice develop Lewy-like and tau pathology associated with age-dependent, detrimental motor impairment. Emmer KL; Waxman EA; Covy JP; Giasson BI J Biol Chem; 2011 Oct; 286(40):35104-18. PubMed ID: 21846727 [TBL] [Abstract][Full Text] [Related]
11. Novel conformation-selective alpha-synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson's disease. Covell DJ; Robinson JL; Akhtar RS; Grossman M; Weintraub D; Bucklin HM; Pitkin RM; Riddle D; Yousef A; Trojanowski JQ; Lee VM Neuropathol Appl Neurobiol; 2017 Dec; 43(7):604-620. PubMed ID: 28386933 [TBL] [Abstract][Full Text] [Related]
12. Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model. Kahle PJ; Neumann M; Ozmen L; Müller V; Odoy S; Okamoto N; Jacobsen H; Iwatsubo T; Trojanowski JQ; Takahashi H; Wakabayashi K; Bogdanovic N; Riederer P; Kretzschmar HA; Haass C Am J Pathol; 2001 Dec; 159(6):2215-25. PubMed ID: 11733371 [TBL] [Abstract][Full Text] [Related]
13. NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathy. Earls RH; Menees KB; Chung J; Gutekunst CA; Lee HJ; Hazim MG; Rada B; Wood LB; Lee JK Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1762-1771. PubMed ID: 31900358 [TBL] [Abstract][Full Text] [Related]
15. Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson's disease. Reyes JF; Ekmark-Léwen S; Perdiki M; Klingstedt T; Hoffmann A; Wiechec E; Nilsson P; Nilsson KPR; Alafuzoff I; Ingelsson M; Hallbeck M Acta Neuropathol Commun; 2021 Mar; 9(1):46. PubMed ID: 33743820 [TBL] [Abstract][Full Text] [Related]
16. Lovastatin ameliorates alpha-synuclein accumulation and oxidation in transgenic mouse models of alpha-synucleinopathies. Koob AO; Ubhi K; Paulsson JF; Kelly J; Rockenstein E; Mante M; Adame A; Masliah E Exp Neurol; 2010 Feb; 221(2):267-74. PubMed ID: 19944097 [TBL] [Abstract][Full Text] [Related]
17. Alterations in mGluR5 expression and signaling in Lewy body disease and in transgenic models of alpha-synucleinopathy--implications for excitotoxicity. Price DL; Rockenstein E; Ubhi K; Phung V; MacLean-Lewis N; Askay D; Cartier A; Spencer B; Patrick C; Desplats P; Ellisman MH; Masliah E PLoS One; 2010 Nov; 5(11):e14020. PubMed ID: 21103359 [TBL] [Abstract][Full Text] [Related]
18. Robust Central Nervous System Pathology in Transgenic Mice following Peripheral Injection of α-Synuclein Fibrils. Ayers JI; Brooks MM; Rutherford NJ; Howard JK; Sorrentino ZA; Riffe CJ; Giasson BI J Virol; 2017 Jan; 91(2):. PubMed ID: 27852849 [TBL] [Abstract][Full Text] [Related]
19. Prion-like spreading of pathological α-synuclein in brain. Masuda-Suzukake M; Nonaka T; Hosokawa M; Oikawa T; Arai T; Akiyama H; Mann DM; Hasegawa M Brain; 2013 Apr; 136(Pt 4):1128-38. PubMed ID: 23466394 [TBL] [Abstract][Full Text] [Related]